×
About 4,135 results

ALLMedicine™ Cholecystitis Center

Research & Reviews  1,451 results

Gallbladder Cancer
http://emedicine.medscape.com/article/278641-clinica

Dec 3rd, 2021 - Practice Essentials Gallbladder cancer is a rare disease that often arises in the setting of chronic inflammation. The American Cancer Society estimates that approximatel 11,980 new cases of gallbladder cancer and cancers of nearby large bile duct...

Gallbladder Empyema
https://emedicine.medscape.com/article/174012-overview

Nov 30th, 2021 - Background Acute cholecystitis in the presence of bacteria-containing bile may progress to suppurative infection in which the gallbladder fills with purulent material, a condition referred to as empyema of the gallbladder. (The underlying cause of...

Gallbladder Empyema
http://emedicine.medscape.com/article/174012-overview

Nov 30th, 2021 - Background Acute cholecystitis in the presence of bacteria-containing bile may progress to suppurative infection in which the gallbladder fills with purulent material, a condition referred to as empyema of the gallbladder. (The underlying cause of...

Noninvasive preoperative differential diagnosis of gallbladder carcinoma and xanthogran...
https://doi.org/10.1002/cam4.4442
Cancer Medicine; Xiao J, Zhou R et. al.

Nov 28th, 2021 - Xanthogranulomatous cholecystitis (XGC) is an extremely rare entity. Due to XGC's clinical and radiological resemblance to gallbladder carcinoma (GBC), intraoperative frozen section during cholecystectomy is often performed to exclude the diagnosi...

Grayscale ultrasonography findings for characterization of gallbladder wall thickening ...
https://doi.org/10.1080/17474124.2021.2011210
Expert Review of Gastroenterology & Hepatology; Rana P, Gupta P et. al.

Nov 27th, 2021 - The accurate characterization of gallbladder wall thickening (GWT) into benign or malignant on ultrasound (US) is a significant challenge. The authors searched the MEDLINE and EMBASE databases for studies reporting two-dimensional grayscale US in ...

see more →

Guidelines  10 results

Endoscopic therapies for gallbladder drainage.
https://doi.org/10.1016/j.gie.2021.05.031
Gastrointestinal Endoscopy; Saumoy M, Yang J et. al.

Aug 5th, 2021 - Endoscopic management of acute cholecystitis has expanded in patients who are considered nonoperative candidates. Traditionally managed with percutaneous cholecystostomy (PC), improvement in techniques and devices has led to increased use of endos...

Lumen-apposing metal stents (with videos).
https://doi.org/10.1016/j.gie.2021.05.020
Gastrointestinal Endoscopy; , Law RJ et. al.

Jul 28th, 2021 - Lumen-apposing metal stents (LAMSs) are a novel class of devices that have expanded the spectrum of endoscopic GI interventions. LAMSs with their dumbbell configuration, short saddle length, and large inner luminal diameter provide favorable stent...

2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643471
World Journal of Emergency Surgery : WJES; Pisano M, Allievi N et. al.

Nov 7th, 2020 - Acute calculus cholecystitis (ACC) has a high incidence in the general population. The presence of several areas of uncertainty, along with the availability of new evidence, prompted the current update of the 2016 WSES (World Society of Emergency ...

ACR Appropriateness Criteria® Right Upper Quadrant Pain.
https://doi.org/10.1016/j.jacr.2019.02.013
Journal of the American College of Radiology : JACR; , Peterson CM et. al.

May 6th, 2019 - Although right upper quadrant pain is a very common clinical presentation, it can be nonspecific. However, acute cholecystitis is very often the diagnosis of exclusion. This review focuses on the recommended imaging evaluation in the most commonly...

TG13 antimicrobial therapy for acute cholangitis and cholecystitis.
https://doi.org/10.1007/s00534-012-0572-0
Journal of Hepato-biliary-pancreatic Sciences; Gomi H, Solomkin JS et. al.

Jan 24th, 2013 - Therapy with appropriate antimicrobial agents is an important component in the management of patients with acute cholangitis and/or acute cholecystitis. In the updated Tokyo Guidelines (TG13), we recommend antimicrobial agents that are suitable fr...

see more →

Drugs  64 results see all →

Clinicaltrials.gov  38 results

Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
https://clinicaltrials.gov/ct2/show/NCT04995380

Nov 8th, 2021 - The SPRIMACC study is a prospective multicenter observational study with the primary endpoint to prospectively validate the Chole-Risk score in predicting a complicated postoperative course (post-operative major complications (Clavien-Dindo>=3a), ...

Trocar-site Infiltration Versus TAP-block
https://clinicaltrials.gov/ct2/show/NCT05094193

Oct 26th, 2021 - For symptomatic gall bladder disorders (cholelithiasis and cholecystitis), laparoscopic cholecystectomy (LC) has been considered as the gold standard treatment. However, these minimally invasive technique is associated with acute moderate pain dur...

Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients
https://clinicaltrials.gov/ct2/show/NCT02972944

Oct 20th, 2021 - The increasing age is one of the main risk factors for developing complicated gallstone disease. Currently, there is lack of good quality studies comparing risks and benefits of early laparoscopic cholecystectomy in the elderly patients. Cholecyst...

EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.
https://clinicaltrials.gov/ct2/show/NCT04197908

Aug 4th, 2021 - The gold standard for treatment of acute calculous cholecystitis is laparoscopic cholecystectomy. Recently, gallbladder drainage with EUS-guided gallbladder drainage (EGBD) has been described as a treatment option. However, whether this is an effe...

Early Laparoscopic Cholecystectomy Versus Percutaneous Cholecystostomy in Grade II Acute Cholecystitis Guidelines
https://clinicaltrials.gov/ct2/show/NCT04979936

Jul 28th, 2021 - A-Study setting: Department of Surgery, main university hospital, Faculty of Medicine, Alexandria University, Egypt. The study was approved by the Ethics Committee of our institution. B-Study design: Retrospective clinical trial C-Study subjects: ...

see more →

News  86 results

EPI worsens with NSAID treatment in patients with osteoarthritis in comorbidity with EPI
https://www.mdedge.com/gihepnews/article/247816/exocrine-pancreatic-insufficiency/epi-worsens-nsaid-treatment-patients

Oct 24th, 2021 - Key clinical point: Treatment with nonsteroidal anti-inflammatory drugs (NSAID) worsened exocrine pancreatic insufficiency (EPI) in patients with primary osteoarthritis in gastrointestinal comorbidity with EPI. Moreover, the trophologic status of.

How One Doctor's Card Game Is Helping ICU Patients
https://www.medscape.com/viewarticle/961411

Oct 22nd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Since the beginning of the pandemic, intensive care units (ICUs) all across the country have seen a massive influx of patients, leaving hospital s...

Neoadjuvant Stereotactic Radiation Shows Early Safety, Feasibility in RCC Inferior Vena Cava Tumor Thrombus
https://www.onclive.com/view/neoadjuvant-stereotactic-radiation-shows-early-safety-feasibility-in-rcc-inferior-vena-cava-tumor-thrombus

Oct 6th, 2021 - Neoadjuvant stereotactic radiation (SABR) followed by radical nephrectomy and thrombectomy is a safe and feasible treatment option for patients with renal cell carcinoma (RCC) and inferior vena cava tumor thrombus (IVC-TT), according to results fr...

Redefining BCLC B, Intermediate-Stage HCC: Is There a Role for Combination Systemic Therapy?
https://www.onclive.com/view/redefining-bclc-b-intermediate-stage-hcc-is-there-a-role-for-combination-systemic-therapy-

Oct 6th, 2021 - Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide with a rising incidence in the United States. BCLC B intermediate stage HCC, defined as patients with unresectable, liver-limited disease and preserved liver f...

BMS Withdraws Romidepsin Relapsed/Refractory PTCL Indication in the United States
https://www.onclive.com/view/bms-withdraws-romidepsin-relapsed-refractory-ptcl-indication-in-the-united-states

Aug 3rd, 2021 - Bristol Myers Squibb (BMS) has made the decision to withdraw in the indication for romidepsin (Istodax) as a monotherapy for the treatment of adult patients with peripheral T-cell lymphoma (PTCL) who have previously received at least 1 therapy.1 ...

see more →

Patient Education  5 results see all →